Salix Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
JPMorgan Healthcare Conference 2013
RALEIGH, N.C. -- January 2, 2013
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company
will present at The 31^st Annual J.P. Morgan Healthcare Conference in San
Francisco, CA on Wednesday, January 9, 2013 at 4:30 p.m. PT (7:30 p.m. ET).
Interested parties can access a live audio web cast of the presentation at
http://www.salix.com. A replay of the presentation will be available at the
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina,
develops and markets prescription pharmaceutical products for the treatment of
gastrointestinal diseases. Salix’s strategy is to in-license late-stage or
marketed proprietary therapeutic drugs, complete any required development and
regulatory submission of these products, and market them through the Company’s
gastroenterology specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol
For more information, please visit our Website at www.salix.com or contact the
Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook
(www.facebook.com/SalixPharma). Information on our web site is not
incorporated in our SEC filings.
Salix Pharmaceuticals, Ltd.
Adam C. Derbyshire
Executive Vice President and Chief Financial Officer
G. Michael Freeman
Associate Vice President, Investor Relations
and Corporate Communications
Press spacebar to pause and continue. Press esc to stop.